86.90.E - Healthcare
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
33.13.Z - Repair and maintenance of electronic and optical devices
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
70.22.Z - Head office activities and management consultancy
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -94,9 | -95,1 | -36,6 | 61,6 |
EBITDA | -95,9 | -91 | -46,6 | 48,9 |
Short time liabilities | 69,1 | 31,1 | 536,3 | 1622 |
Equity capital | 415 | 319,9 | 283,4 | -11,4 |
Operating profit (EBIT) | -105,8 | -100 | -48,4 | 51,6 |
Assets | 484,1 | 417,7 | 886,3 | 112,2 |
Net profit (loss) | -94,9 | -95,1 | -36,6 | 61,6 |
Cash | 0 | 1,8 | 31,7 | 1682,6 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 69,1 | 97,8 | 603 | 516,5 |
Working assets | 475,1 | 417,7 | 886,3 | 112,2 |
Depreciation | 9,9 | 9 | 1,8 | -79,6 |
% | % | % | p.p. | |
Profitability of capital | -22,9 | -29,7 | -12,9 | 16,8 |
Equity capital to total assets | 85,7 | 76,6 | 32 | -44,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 6.644904136657715 | 13.412639617919922 | 1.6526761054992676 | -11,7 |
Net dept to EBITDA | -0.051952481269836426 | -0.7504502534866333 | -11.633183479309082 | -10,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane